Skip to content

US · CLOV · MEDICAL - HEALTHCARE PLANS

Clover Health Investments, Corp. (CLOV) intrinsic value and stock valuation

$3.73as of 2026-11-21 · Mkt cap 2.15B

Data updated · price as of 2026-11-21

Strongly undervaluedIC value is more than 50% above the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Clover Health Investments, Corp. DCF and intrinsic value

InvestorsCraft values CLOV with the Chepakovich two-stage DCF model — currently rated strongly undervalued. How the model works · Run your own DCF prefilled from CLOV’s statements →

Clover Health Investments, Corp. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Healthcare Plans Wilmington, DE 19801 cloverhealth.com

How the business is doing

Fiscal 2018–2025, USD

Revenue
$1.92B+23.4% 5y CAGRd
20182025
Net income
-$-85.55M
20182025
Free cash flow
-$-68.98M
20182025
Total equity
$308.7M
20182025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2018–2025, USD
20252024202320222021
Revenue$1.92B$1.37B$1.26B$1.1B$1.47B
Operating income-$-85.53M-$-45.75M-$-205.33M-$-286.66M-$-636.99M
Net income-$-85.55M-$-43.01M-$-213.36M-$-339.57M-$-587.76M
EPSd-$-165.4K-$-87.77K-$-442.49K-$-713.02K-$-1.25M
Operating cash flow-$-66.93M$34.8M-$-115.87M-$-203.93M-$-282.33M
Capital expenditure-$-2.04M-$-1.56M-$-580K-$-4.47M-$-720K
Free cash flow-$-68.98M$33.3M-$-116.45M-$-208.39M-$-283.05M
Total assets$541M$580.7M$570.7M$808.6M$950.8M
Total debt$0.00$0.00$4.66M$5.86M$27.8M
Net debt-$-78.3M-$-194.54M-$-111.74M-$-97.93M-$-272.14M
Total equity$308.7M$341.1M$286.4M$356.9M$539.3M
Cash and short-term investments$95.4M$221.5M$236.2M$334.8M$615.3M
Income statement
20252024202320222021
Revenue$1.92B$1.37B$1.26B$1.1B$1.47B
Cost of revenue$1.57B$1.01B$1B$993.1M$1.55B
Gross profit$355.9M$364.8M$256M$103.5M-$-79.18M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$176.3M$408.9M$440.3M$482.4M$445.8M
Other expenses$265.1M$1.62M$21M-$-92.26M$112.1M
Operating expenses$441.4M$410.6M$461.3M$390.1M$557.8M
Cost and expenses$2.01B$1.42B$1.47B$1.38B$2.11B
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$0.00$0.00$10K$1.36M$16.9M
Depreciation and amortization$1.69M$1.33M$2.51M$1.19M$1.25M
Ebitda-$-83.86M-$-44.94M-$-207.63M-$-252.03M-$-569.6M
Operating income-$-85.53M-$-45.75M-$-205.33M-$-286.66M-$-636.99M
Total other income/expenses, net-$-20K-$-520K-$-4.82M$32.1M$49.2M
Income before tax-$-85.55M-$-46.27M-$-210.15M-$-254.58M-$-587.76M
Income tax expense$0.00$0.00$0.00$0.00$0.00
Net income-$-85.55M-$-43.01M-$-213.36M-$-339.57M-$-587.76M
Weighted average shares outstanding$517.2M$490M$482.2M$476.2M$470.9M
Weighted average diluted shares outstanding$517.2M$490M$482.2M$476.2M$470.9M
Balance sheet
20252024202320222021
Cash and short-term investments$95.4M$221.5M$236.2M$334.8M$615.3M
Net receivables$158.7M$92.8M$86.2M$167.5M$109.4M
Inventory$0.00$0.00$0.00$0.00$0.00
Total current assets$307.9M$343.1M$428M$625M$752.6M
Property, plant and equipment, net$6.38M$5.31M$5.08M$9.78M$7.65M
Goodwill and intangible assets$2.99M$2.99M$2.99M$20M$4.23M
Long-term investments$187.1M$201.7M$121M$138.1M$175.9M
Total non-current assets$233.2M$237.6M$142.7M$183.6M$198.3M
Total assets$541M$580.7M$570.7M$808.6M$950.8M
Accounts payable$36.2M$34.6M$37.2M$32.5M$28.1M
Short-term debt$0.00$0.00$1.67M$1.83M$3.06M
Deferred revenue$0.00$0.00$3.1M$0.00$138.6M
Total current liabilities$208.8M$213.5M$261.1M$431.5M$372.6M
Long-term debt$0.00$0.00$3M$4.03M$24.8M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$23.5M$26.1M$23.2M$20.2M$38.9M
Capital lease obligations$0.00$0.00$4.66M$5.86M$7.89M
Total liabilities$232.3M$239.6M$284.3M$451.7M$411.5M
Common stock$50K$50K$50K$50K$50K
Retained earnings-$-2.29B-$-2.2B-$-2.16B-$-1.95B-$-1.62B
Accumulated other comprehensive income (loss)$530K-$-1.58M-$-2.37M-$-9.37M-$-1.93M
Total equity$308.7M$341.1M$286.4M$356.9M$539.3M
Total investments$204.1M$228.7M$240.8M$369.1M$491.2M
Total debt$0.00$0.00$4.66M$5.86M$27.8M
Net debt-$-78.3M-$-194.54M-$-111.74M-$-97.93M-$-272.14M
Cash flow statement
20252024202320222021
Net income-$-85.55M-$-43.01M-$-213.36M-$-339.57M-$-587.76M
Depreciation and amortization$1.69M$1.33M$2.51M$1.19M$1.25M
Stock-based compensation$103.7M$114.3M$140.9M$164.3M$163.7M
Change in working capital-$-84.2M$12.9M-$-55.43M-$-2.36M$192.7M
Accounts receivable-$-65.95M-$-6.55M$0.00-$-8.03M-$-9.39M
Inventory$0.00$0.00$0.00$0.00$9.39M
Accounts payable$1.65M-$-2.62M$4.74M$7.63M$5.31M
Net cash provided by operating activities-$-66.93M$34.8M-$-115.87M-$-203.93M-$-282.33M
Investments in property, plant and equipment-$-2.04M-$-1.56M-$-580K-$-4.47M-$-720K
Acquisitions, net$0.00$0.00$0.00-$-16.2M$434.7M
Net cash used for investing activities$4.08M$560K$140M$95.1M-$-435.45M
Common stock issued$1.81M$900K$1.15M$1.4M$289.9M
Common stock repurchased-$-55.2M-$-18.26M-$-6.22M-$-6.36M-$-150K
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities-$-53.38M-$-17.36M-$-33.86M-$-4.96M$925.4M
Net change in cash-$-116.24M$18.1M-$-9.72M-$-113.75M$207.6M
Cash at end of period$78.3M$194.5M$176.5M$186.2M$300M
Operating cash flow-$-66.93M$34.8M-$-115.87M-$-203.93M-$-282.33M
Capital expenditure-$-2.04M-$-1.56M-$-580K-$-4.47M-$-720K
Free cash flow-$-68.98M$33.3M-$-116.45M-$-208.39M-$-283.05M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Clover Health Investments, Corp.

        Clover Health Investments, Corp. is a U.S.-based firm specializing in Medicare Advantage insurance. The company leverages its proprietary software platform, the Clover Assistant, to provide both Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) health plans for individuals eligible for Medicare. In addition to its insurance operations, Clover Health also engages in non-insurance-related business ventures. The company was established in 2014 and its main office is located in Franklin, Tennessee.

        CEO
        Andrew Toy
        Employees
        724
        Beta
        2.42

        Explore

        Frequently asked questions

        What is the intrinsic value of Clover Health Investments, Corp. (CLOV)?

        Clover Health Investments, Corp. (CLOV) is currently strongly undervalued based on the InvestorsCraft IC model — IC value is more than 50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is CLOV undervalued?

        CLOV trades at a price of $3.73 (Nov 21, 2026): strongly undervalued — IC value is more than 50% above the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.